Draegerwerk AG & Co. KGaA · XETR:DRW8

Draegerwerk AG & Co. KGaA — Drägerwerk AG & Co. KGaA — Shareholder Meeting (2004)

31 slides from Draegerwerk AG & Co. KGaA's shareholder meeting presentation, Nov 24, 2004

  1. Slide 1: Welcome to the Annual Shareholders' Meeting of Drägerwerk AG

    Welcome to the Annual Shareholders‘ Meeting of Drägerwerk AG 1

  2. Slide 2: Dräger Group continues on the road to success

    Dräger Group continues on the road to success – Group restructuring process completed > Focus on Dräger Medical and Dräger Safety core business > Sale of Dräger Aerospace and service companies > Highlights 2003 – Group accounts 2003 showing record numbers > Budgeted goals achieved > Profitable susta

  3. Slide 3: Legal Structure of the Dräger Group

    Legal Structure of the Dräger Group 6.350.000 common shares Drägerwerk AG 6.350.000 preferred shares Dräger Medical Dräger Safety Service Companies 65 % 100 % 100 % Subsidiaries Subsidiaries Dräger Interservices GmbH worldwide worldwide Dräger InTek GmbH Focus on core business completed 3

  4. Slide 4: Dräger-Group global presence

    Dräger-Group global presence Lübeck Danvers Hagen Svenljunga Telford Medical Safety Medical Safety Blyth Peking Safety Safety Plymouth Safety Shanghai Medical Best Medical Pittsburgh Safety The most important production locations 4

  5. Slide 5: Group key figures at a glance

    Group key figures at a glance 2002 2003 Variance Net sales million € 1,333.0 1,413.5 6.0 % Operating EBIT* million € 71.9 96.4 34.1 % EBIT margin 5.4 % 6.8 % Capital Employed (CE) million € 531.5 857.3 61.3 % ROCE (Return on CE) 13.5 % 11.2 % Annual net profit ** million € 19.8 37.8 90.9 % Minoritie

  6. Slide 6: Development of net sales for the Dräger-Group

    Development of net sales for the Dräger-Group 1,414 1,333 1,257 1,137 Million € 1,021 28 % 28 % share in Germany 30 % 72 % 72 % 33 % 70 % 35 % 67 % share outside Germany 65 % 1999 2000 2001 2002 2003 6

  7. Slide 7: Net sales 2003 per subgroup

    Net sales 2003 per subgroup Medical 64.9 % Safety 33.8 % Others incl. consolidation 1.3 % 7

  8. Slide 8: Dräger-Group net sales 2003 per region

    Dräger-Group net sales 2003 per region Rest of Europe 8.5 % USA 17.6 % EU (w/o Germany) Asia/Pacific 29.0 % 14.3 % Africa 2.0 % Germany 28.6 % 8

  9. Slide 9: EBIT development of the Dräger-Group

    EBIT development of the Dräger-Group 96.4 71.9 EBIT* before one-time expenses** 51.9 € million 42.0 32.8 1999 2000 2001 2002 2003 * profit before interest expenses and taxes ** € 47.7 million restructuring expenses in 2000 and one-time expenses from JV with Siemens (2002: € 5.6 million, 2003: € 32.4

  10. Slide 10: Income statement of the Dräger-Group

    Income statement of the Dräger-Group 2002 in 2003 in Variance Mio € % Mio € % Assets Fixed assets 201.0 23.8 336.9 28.2 67.6 % Inventories 213.0 25.2 203.0 17.0 – 4.7 % Receivables/cash on hand 431.5 51.0 656.6 54.8 52.2 % Total assets 845.5 100.0 1,196.5 100.0 41.5 % Equity & Liabilities Total equi

  11. Slide 11: Dräger-Group headcount (annual average)

    Dräger-Group headcount (annual average) 11,000 10,334 10,000 9,535 9,865 9,275 9,377 9,000 Abroad: 8,000 Increase due to Siemens and 7,000 3,289 3,356 3,630 4,022 4,678 consolidation of 6,000 at-equity companies 5,000 5,986 6,021 5,905 5,843 5,656 4,000 3,000 Germany: 2,000 Reduction due to sale of

  12. Slide 12: Source and use of value added

    Source and use of value added 2002 in 2003 in Mio € % Mio € % Source Group’s total oper.performance 1,384.5 100.0 1,476.4 100.0 Pre-payments/depreciation/ JV one-time expenses (789.4) – 57.0 ( 825.7) – 55.9 Net value added 595.1 43.0 650.7 44,1 . Use 87.1 Employees 528.7 88.8 566.5 4.2 Treasury / ta

  13. Slide 13: Reduction of environmental load at the Lübeck location

    Reduction of environmental load at the Lübeck location measured against sales 100 90 80 70 60 50 40 30 energy consumption 20 water consumption 10 CO2-emission solid waste 0 % 1995 1996 1997 1998 1999 2000 2001 2002 2003 A continuous decline in environmental load indices at the Lübeck location as mea

  14. Slide 14: Development of Dräger preferred share

    Development of Dräger preferred share 14

  15. Slide 15: Group key figures 1. quarter 2004

    Group key figures 1. quarter 2004 Q1/2003 Q1/2004 Variance Order entry million € 330.0 349.9 6.0 % Net sales million € 280.2 313.0 11.7 % Operating EBIT* million € 12.5 14.8 18.4 % EBIT margin 4.5 % 4.7 % Annual net profit million € 2.2 13.4 ** Average headcount 10,147 10,122 – 0.2 % * Profit before

  16. Slide 16: Dräger-Group – goals 2006

    Dräger-Group – goals 2006 – Focusing on the core competencies of Medical and Safety – Securing and extension of the leading market position worldwide > Customized innovative products and services > Stronger growth in Asia and USA > Increase of net sales: 6 % p.a. – Optimization of the business proce

  17. Slide 17: Dräger Medical

    Dräger Medical 17

  18. Slide 18: Dräger Medical – results 2003

    Dräger Medical – results 2003 – Profitability goal from restructuring plan of 2000 reached: EBIT margin of 10 % of net sales – JV with Siemens implemented quickly and successfully: Integration activities in 190 countries completed by 9/2003 – Continued conversion of the subgroup into a process-contr

  19. Slide 19: Dräger Medical – results 2003

    Dräger Medical – results 2003 Actual Actual Variance 2002 2003 Net sales million € 848.3 917.7 8.2 % Operating EBIT* million € 76.6 91.4 19.3 % EBIT margin 9.0 % 10.0 % Capital Employed million € 328.8 694.2 111.7 % ROCE million € 23.3 % 13.2 % Annual net profit** million € 40.7 38.7 – 4.9 % Headcou

  20. Slide 20: Dräger Medical – Prospects 2004

    Dräger Medical – Prospects 2004 Q1/2004 results Q1/2003 Q1/2004 Variance Net sales million € 166.6 200.8 20.6 % Operating EBIT* million € 10.4 11.2 7.7 % EBIT margin 6.2 % 5.6 % Net annual profit** million € 5.5 6.9 25.5 % Headcount at quarter end 5,180 5,739 10.8 % Pre-payments in sales & service f

  21. Slide 21: Dräger Medical Successful restructuring process since 2000

    Dräger Medical Successful restructuring process since 2000 Net sales in million € EBIT in million € R&D in million € before JV one-time expenses 1.200 140 100 1.090 122 1.100 0, 5% 120 84 1.000 GR1 % C A 918 80 ,4 % 100 91 14 ,0 900 848 GR 92 A 69 805 C R 80 G 800 77 CA 732 60 700 60 52 49 49 600 39

  22. Slide 22: Dräger Medical – mid-term goals

    Dräger Medical – mid-term goals – Global standardization of the business processes until end of 2006 – Further optimization of the product portfolio at the acute point of care. In 2004 integration of Air-Shields, specialist in incubator technology – Further extension of the sales and service activit

  23. Slide 23: Dräger Medical Long-term competitive advantages

    Dräger Medical Long-term competitive advantages Dräger Medical brand known worldwide for quality and innovation Global sales and service network, long-term customer relationships Large installed base Global orientation of the business processes Extensive product portfolio allows process-optimizing s

  24. Slide 24: Dräger Safety

    Dräger Safety 24

  25. Slide 25: Dräger Safety – results 2003

    Dräger Safety – results 2003 – Profit (EBIT), return on capital employed (ROCE) and net sales higher than budgeted. Compensation of exchange rate influences on the EBIT amounting to € 7 million – In accordance with the Safety strategy profit (EBIT) increased faster than sales; process improvement me

  26. Slide 26: Dräger Safety – results 2003

    Dräger Safety – results 2003 – Integration of the Business Unit Dräger Service into Business Units Personal Protection and Gas Detection Technology – Establishing of the new Business Unit Dräger Safety Solutions to offer complex services – Acquisition of AMEC (fire training containers) and PILLER (N

  27. Slide 27: Dräger Safety – results 2003

    Dräger Safety – results 2003 Actual Actual Variance Actual 2003 Variance based (corrected for on 2002 2003 currencies) comparable comparable values of 2002 with2002 Net sales million € 471.1 477.4 1.3 % 504 7% EBIT* million € 41.3 39.7 – 3.9 % 47 14 % EBIT margin 8.8 % 8.3 % 9.3 % Capital Employed m

  28. Slide 28: Dräger Safety – prospects 2004

    Dräger Safety – prospects 2004 Q1/2004 results Q1/2003 Q1/2004 Variance Net sales million € 109.3 113.2 3.6 % EBIT* million € 7.9 9.4 19.0 % EBIT margin 7.3 % 8.3 % Capital Employed million € 173 176 1.7 % Average headcount 3,379 3,405 0.8 % – with 3.6 % growth in sales à 19.0 % growth in profits ]

  29. Slide 29: Dräger Safety – strategy

    Dräger Safety – strategy – Global process standardization and hence increased efficiency in the departments concerned (e.g. logistics, sales organization, production process and all administrative processes related therewith) – Establishing of the service sector (Dräger Safety Solutions) as a featur

  30. Slide 30: Dräger Safety Pioneering Solutions

    Dräger Safety – Our Approach Dräger Safety Pioneering Solutions 30

  31. Slide 31: Disclaimer

    Disclaimer Estimates: This presentation contains a number of forecasts and estimates which are based on present expectations, anticipations and predictions on the part of the Executive Board and the information it currently has. Such estimates should not be construed as a warranty that the future de

Drägerwerk AG & Co. KGaA — Shareholder Meeting (2004) on 6ix